CN117144053A - Aspergillus fumigatus detection primer set, kit and application thereof - Google Patents
Aspergillus fumigatus detection primer set, kit and application thereof Download PDFInfo
- Publication number
- CN117144053A CN117144053A CN202311401969.5A CN202311401969A CN117144053A CN 117144053 A CN117144053 A CN 117144053A CN 202311401969 A CN202311401969 A CN 202311401969A CN 117144053 A CN117144053 A CN 117144053A
- Authority
- CN
- China
- Prior art keywords
- primer
- aspergillus fumigatus
- kit
- detection
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 74
- 241001225321 Aspergillus fumigatus Species 0.000 title claims abstract description 59
- 229940091771 aspergillus fumigatus Drugs 0.000 title claims abstract description 58
- 238000012360 testing method Methods 0.000 claims abstract description 25
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002773 nucleotide Substances 0.000 claims description 19
- 125000003729 nucleotide group Chemical group 0.000 claims description 19
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 229960002685 biotin Drugs 0.000 claims description 9
- 235000020958 biotin Nutrition 0.000 claims description 9
- 239000011616 biotin Substances 0.000 claims description 9
- 238000011901 isothermal amplification Methods 0.000 claims description 9
- 238000003908 quality control method Methods 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 5
- -1 (NH) 4 ) 2 SO 4 Chemical compound 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 26
- 238000000034 method Methods 0.000 abstract description 11
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 238000013399 early diagnosis Methods 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 208000036641 Aspergillus infections Diseases 0.000 abstract description 4
- 206010017533 Fungal infection Diseases 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 4
- 208000031888 Mycoses Diseases 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 150000007523 nucleic acids Chemical group 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 241000228212 Aspergillus Species 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- 108010053770 Deoxyribonucleases Proteins 0.000 description 4
- 102000016911 Deoxyribonucleases Human genes 0.000 description 4
- 208000037026 Invasive Fungal Infections Diseases 0.000 description 4
- 238000007397 LAMP assay Methods 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000004005 microsphere Substances 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 101000686153 Homo sapiens Ras-related GTP-binding protein A Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 102100025001 Ras-related GTP-binding protein A Human genes 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 201000009085 invasive aspergillosis Diseases 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 206010006473 Bronchopulmonary aspergillosis Diseases 0.000 description 1
- 206010006474 Bronchopulmonary aspergillosis allergic Diseases 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 102100031822 Optineurin Human genes 0.000 description 1
- 101710131459 Optineurin Proteins 0.000 description 1
- 208000004430 Pulmonary Aspergillosis Diseases 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000006778 allergic bronchopulmonary aspergillosis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/68—Aspergillus fumigatus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The application provides an aspergillus fumigatus detection primer set, a kit and application thereof, belongs to the technical field of fungus detection, and solves the problem of inaccurate aspergillus fumigatus detection in the prior art. The aspergillus fumigatus detection primer group provided by the application has high sensitivity and strong specificity, and the detection limit is as low as 500copies/mL, thereby being beneficial to early screening and early diagnosis of aspergillus fumigatus infection and being convenient for timely intervention treatment and disease control. The kit for detecting aspergillus fumigatus provided by the application adopts a isothermal amplification-nucleic acid colloidal gold chromatography method, can complete detection reaction within 35min, and has simple and convenient result judgment; the kit provided by the application has low single detection cost and low requirements on instruments and equipment, is suitable for basic medical units, can perform home self-test, and is beneficial to early diagnosis of fungal infection.
Description
Technical Field
The application relates to the technical field of fungus detection, in particular to an aspergillus fumigatus detection primer group, a kit and application thereof.
Background
Aspergillus fumigatusAspergillus fumigatus) The aspergillus is a saprophytic fungus widely existing in the nature, can generate a large amount of conidia to diffuse into the air for wide spread, and enters the body through respiratory tract or wound to cause infection, thus causing great harm to human health. Aspergillus fumigatus-induced diseases mainly include invasive Aspergillus diseases, chronic pulmonary aspergillosis, aspergillus swelling, and allergic diseases such as asthma and allergic bronchopulmonary aspergillosis, of which invasive aspergillosis (Invasive aspergillosis, IA) is the most serious. Whereas, of the systemic infections caused by aspergillus, about 90% are caused by aspergillus fumigatus. Researches show that the early diagnosis rate of patients with invasive fungal infection death is only 12% -60%, and failure to accurately diagnose and actively treat is a main factor with high mortality rate of invasive fungal infection. Therefore, the development of an early diagnosis method for aspergillus fumigatus infection is a precondition for targeted treatment of fungal infection, and has important significance for reducing the mortality rate of fungal infection.
According to the "laboratory diagnostic methods for invasive mycoses clinical application expert consensus" (2022 edition), the current clinical tests for invasive mycoses can be divided into two categories, histological and microbiological tests. Although the histological examination can directly obtain pathogenic bacteria at an infection site, the culture step is still needed when the pathogenic bacteria load is low, the time consumption is long, and the method is not suitable for early diagnosis. In microbiological examination, direct microscopic examination has the problems of false negative, low sensitivity and the like. Fungus culture identification also has the problem of low positive rate and takes longer time. The G test and GM test in serological tests are widely used for early screening and continuous detection of aspergillus infections, but in the presence of false positives.
The existing aspergillus fumigatus detection method based on the molecular biology method is poor in specificity, and the flow is mostly dependent on a specific detection instrument, so that convenience is lacking, for example, the method for detecting aspergillus fumigatus by using the fluorescent quantitative PCR technology disclosed in Chinese patent CN108707691A and CN109811079A is poor, but the technology depends on the operation of the fluorescent detection instrument and professionals. Chinese patent CN113335731a discloses that, although a detection technology based on RPA and CRISPR is used, a higher detection sensitivity is obtained, the result still needs the assistance of a fluorescence detection instrument during interpretation, which is not beneficial to the convenience of detection, and the above technical schemes have risks of false positive and inaccurate detection.
Disclosure of Invention
The application aims to provide an aspergillus fumigatus detection primer group, a kit and application thereof, so as to solve the problem of inaccurate aspergillus fumigatus detection in the prior art.
In order to achieve the above object, the present application provides the following technical solutions:
the application provides an aspergillus fumigatus detection primer group, which comprises the following primers:
a primer AF F3 with a nucleotide sequence shown as SEQ ID NO. 1;
a primer AF FIP with a nucleotide sequence shown as SEQ ID NO. 2;
the nucleotide sequence is shown as a primer AF LF shown as SEQ ID NO. 3;
the nucleotide sequence is shown as a primer AF BIP shown in SEQ ID NO. 4;
the nucleotide sequence is shown as a primer AF LB shown in SEQ ID NO. 5;
the nucleotide sequence is shown as a primer AF B3 shown in SEQ ID NO. 6.
Preferably, the 5' end of the primer AF FIP is marked with a fluorescent group;
the 5' end of the primer AF LB is marked with biotin.
Preferably, the fluorophore is FAM or FITC.
The application also provides application of the aspergillus fumigatus detection primer group in preparation of a kit for detecting aspergillus fumigatus.
The application also provides a kit for detecting aspergillus fumigatus, which comprises a detection reagent and the aspergillus fumigatus detection primer group.
Preferably, the final concentration of the primer AF FIP in the kit is 1.6-2.4 mu mol/L;
the final concentration of the primer AF BIP in the kit is 1.6-2.4 mu mol/L.
Preferably, the detection reagent comprises isothermal amplification buffer, dNTPs and Bst DNA polymerase.
Preferably, the isothermal amplification buffer comprises Tris-HCl, (NH) 4 ) 2 SO 4 、KCl、MgSO 4 And Tween-20.
Preferably, the kit further comprises a colloidal gold immunochromatographic test strip.
Preferably, the colloidal gold immunochromatographic test strip comprises a bottom plate, a sample pad, an interpretation area and a water absorption pad; the sample pad, the interpretation area and the water absorption pad are sequentially arranged on the bottom plate; the interpretation area is sequentially provided with a detection line and a quality control line;
FAM antibodies are coated in the detection line, and the concentration of the FAM antibodies is 0.05-0.15 mg/mL;
the quality control line is coated with a biotin-BSA solution, and the concentration of the biotin-BSA solution is 1.5-3 mg/mL.
The application has the beneficial effects that:
the aspergillus fumigatus detection primer group provided by the application has high sensitivity and strong specificity, and the detection limit is as low as 500copies/mL, thereby being beneficial to early screening and early diagnosis of aspergillus fumigatus infection and being convenient for timely intervention treatment and disease control.
The kit for detecting aspergillus fumigatus provided by the application adopts a isothermal amplification-nucleic acid colloidal gold chromatography method, can complete detection reaction within 35min, and has simple and convenient result judgment; the kit provided by the application has low single detection cost and low requirements on instruments and equipment, is suitable for basic medical units, can perform home self-test, and is beneficial to early diagnosis of deep fungal infection.
Drawings
FIG. 1 is a graph of the repeated detection results of the present application;
FIG. 2 is a graph showing the results of the specific assay of the present application.
Detailed Description
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs. In case of conflict, the present specification, definitions, will control.
As used herein, the term "prepared from …" is synonymous with "comprising. The terms "comprising," "including," "having," "containing," or any other variation thereof, as used herein, are intended to cover a non-exclusive inclusion.
The conjunction "consisting of …" excludes any unspecified element, step or component. If used in a claim, such phrase will cause the claim to be closed, such that it does not include materials other than those described, except for conventional impurities associated therewith. When the phrase "consisting of …" appears in a clause of the claim body, rather than immediately following the subject, it is limited to only the elements described in that clause; other elements are not excluded from the stated claims as a whole.
When an equivalent, concentration, or other value or parameter is expressed as a range, preferred range, or a range bounded by a list of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when ranges "1 to 5" are disclosed, the described ranges should be construed to include ranges "1 to 4", "1 to 3", "1-2 and 4-5", "1-3 and 5", and the like. When a numerical range is described herein, unless otherwise indicated, the range is intended to include its endpoints and all integers and fractions within the range.
The application provides an aspergillus fumigatus detection primer group, which comprises the following primers:
a primer AF F3 with a nucleotide sequence shown as SEQ ID NO. 1;
a primer AF FIP with a nucleotide sequence shown as SEQ ID NO. 2;
the nucleotide sequence is shown as a primer AF LF shown as SEQ ID NO. 3;
the nucleotide sequence is shown as a primer AF BIP shown in SEQ ID NO. 4;
the nucleotide sequence is shown as a primer AF LB shown in SEQ ID NO. 5;
a primer AF B3 with a nucleotide sequence shown as SEQ ID NO. 6;
the target of the primer group is in the aspergillus fumigatus genomeANXC4The 543 to 762 nucleic acid sequences of the coding region (CDS).
In the present application, the 5' end of the primer AF FIP is preferably labeled with a fluorescent group, and the fluorescent group is preferably FAM or FITC; the 5' end of the primer AF LB is marked with biotin.
The application also provides application of the aspergillus fumigatus detection primer group in preparation of a kit for detecting aspergillus fumigatus, and the kit for detecting aspergillus fumigatus is preferably a kit adopting a isothermal amplification principle.
The application also provides a kit for detecting aspergillus fumigatus, which comprises a detection reagent and the aspergillus fumigatus detection primer group, wherein the final concentration of the primer AF FIP in the kit is preferably 1.6-2.4 mu mol/L, more preferably 1.8-2.2 mu mol/L, the final concentration of the primer AF BIP in the kit is preferably 1.6-2.4 mu mol/L, more preferably 1.8-2.2 mu mol/L, the final concentration of the primer AF F3 in the kit is preferably 0.1-0.3 mu mol/L, more preferably 0.15-0.25 mu mol/L, the final concentration of the primer AF LB in the kit is preferably 0.5-0.8 mu mol/L, more preferably 0.6-0.7 mu mol/L, the final concentration of the primer AF B3 in the kit is preferably 0.1-0.3 mu mol/L, more preferably 0.15-0.2 mu mol/L, more preferably 0.25 mu mol/L, and the final concentration of the primer AF LB in the kit is preferably 0.5-0.8 mu mol/L.
In the present application, the detection reagent preferably comprises an isothermal amplification buffer, preferably comprising Tris-HCl, (NH), dNTP and Bst DNA polymerase 4 ) 2 SO 4 、KCl、MgSO 4 And Tween-20, wherein the concentration of Tris-HCl in the kit is preferably 15-18 mmol/L, and more preferably 16-17 mmol/L; in the kit (NH) 4 ) 2 SO 4 The final concentration of KCl in the kit is preferably 7 to 9mmol/L, more preferably 7.5 to 8.5mmol/L, the final concentration of KCl in the kit is preferably 11 to 13mmol/L, more preferably 11.5 to 12.5mmol/L, and the MgSO in the kit 4 The final concentration of Tween-20 in the kit is preferably 0.06-0.1%, more preferably 0.07-0.09%, and the final concentration of dNTP in the kit is preferably 055-0.65 mmol/L, more preferably 0.58-0.62 mmol/L, and the final enzyme activity of Bst DNA polymerase in the kit is preferably 0.2-0.3U/mL, more preferably 0.24-0.28U/mL.
In the present application, the method of using the kit preferably comprises the steps of: (1) extracting DNA of a sample to be detected by adopting a genome DNA extraction kit; (2) reagent configuration: preparing a reaction system by taking 1.5mL centrifuge tubes (DNase/RNase-Free, sterilization), adding isothermal amplification PCR reaction liquid and primer mixed liquid, carrying out vortex oscillation for 10 seconds, centrifuging for standby, and sub-packaging 20 mu L/tube into the PCR reaction tubes (sterile and DNase/RNase-Free); (3) sample adding: transferring 10 mu L of the extracted nucleic acid into each PCR reaction tube, covering a tube cover, centrifuging, and transferring to a PCR detection area; (4) and (3) PCR amplification: and placing the PCR reaction tube into a sample tank for isothermal amplification, reacting for 30min at 60 ℃ to obtain a sample amplification product, and determining whether the sample amplification product contains 543-762 nucleic acid sequences of an ANXC4 coding region (CDS) in an aspergillus fumigatus genome, so as to obtain whether the sample contains aspergillus fumigatus.
In the application, the kit also preferably comprises a colloidal gold immunochromatographic test strip, wherein the colloidal gold immunochromatographic test strip preferably comprises a bottom plate, a sample pad, an interpretation area and a water absorption pad; the sample pad, the interpretation area and the water absorption pad are sequentially arranged on the bottom plate; the interpretation area is sequentially provided with a detection line and a quality control line; the read zone preferably comprises a conjugate pad and a nitrocellulose membrane; the sample pad, the bonding pad, the nitrocellulose membrane and the water absorbing pad are sequentially overlapped with each other in a staggered manner to form a strip shape and then are adhered to a bottom plate, and the bottom plate is a PVC plate; the binding pad is sprayed with a streptavidin marked tracer marker, the tracer marker is nano particles comprising colloidal gold, latex microspheres and fluorescent microspheres, a C line (quality control line) and a T line (detection line) are sequentially arranged on a nitrocellulose membrane from absorbent paper to the binding pad, a biotin-BSA solution is coated in the C line region, and FAM antibodies are coated in the T line region. The concentration of the biotin-BSA solution is preferably 1.5-3 mg/mL, the concentration of the FAM antibody is preferably 0.05-0.15 mg/mL, and the FAM antibody is preferably a rabbit anti-FAM antibody; in the application, the test strip is assembled into the shell to prepare the detection card.
The detection principle of the test strip provided by the application is as follows: the label marker marked by streptavidin is sprayed on the binding pad in the interpretation area, the label marker is nano particles including colloidal gold, latex microspheres and fluorescent microspheres, a biotin-BSA is coated on a C line of a nitrocellulose membrane, and a rabbit anti-FAM antibody is coated on a T line; meanwhile, when the double-chain amplification product with FITC/FAM and biotin marks flows through the test strip, the double-chain amplification product can be recognized and captured by specific antibodies on the colloidal gold labeled antibody and nitrocellulose membrane, a red strip is formed in a corresponding T line area (detection line), unbound colloidal gold labeled antibody is chromatographed to a C line area (quality control line) along with buffer solution, and specific antigens fixed on the membrane are recognized and captured to form the red strip, so that quality control of the test strip is completed.
Result determination criteria:
the C line shows red line, and the T line shows red line, which indicates that the detected sample is positive;
the C line shows red line, and the T line does not show red line, which indicates that the detected sample is negative;
the C line has no red line indicating a test card failure.
In the application, the kit is also provided with a conventional DNA extraction kit, a chromatographic buffer solution, and more than five standby disposable pipettes and reaction tubes; the loop-mediated isothermal amplification reaction solution, the primer mixture and the chromatographic buffer solution are placed in independent reaction tubes for aseptic sealing.
The technical solutions provided by the present application are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present application.
Example 1
Taking the 543 rd to 762 th positions of an ANXC4 coding region (CDS) in an aspergillus fumigatus genome as a specific detection target for detecting aspergillus fumigatus, designing a primer group according to a target region sequence, wherein the nucleotide sequence of the primer group is as follows (the sequences are 5'to 3'):
primer AF F3: TCCAGTTATGTCCGGGGC, shown in SEQ NO.1, is located at positions 543-560 on the ANXC4 CDS region;
primer AF FIP: TGGGATGATGACCGGGAATGTCCTCCAGCCAAGCACGATT, shown as SEQ NO.2, is composed of two CDS separated fragments, and is respectively positioned at 575 th to 592 th and 622 th to 643 th positions on the CDS;
primer AF LF: ATGACGGGAACGCGACG, shown in SEQ NO.3, at positions 593-609 of the CDS region;
primer AF BIP: CAGTTCCAGTATGCCATGCCGTCGGTGCAGATGATGTCGG, shown in SEQ NO.4, consists of two fragments spaced apart on the CDS at positions 661-682 and 715-732, respectively, on the CDS;
primer AF LB: ACAGTATGGCCAATTCCAGCCT, shown in SEQ NO.5, at positions 684-705 of the CDS region;
primer AF B3: ACACTCTGGAATGGGGGC, SEQ NO.6, at positions 745-762 of the CDS region;
wherein, the 5 'end of the primer AF FIP is marked with FAM group, and the 5' end of the primer AF LB is marked with biotin.
Example 2
The difference from example 1 is only that the 5 '-end of the primer AF FIP is labeled with FITC group and the 5' -end of the primer AF LB is labeled with biotin.
Example 3
Preparing the components of the kit: the method comprises the steps of mixing the primer combination in the embodiment 1, loop-mediated isothermal amplification reaction liquid and a nucleic acid colloidal gold detection card;
the loop-mediated isothermal amplification reaction solution comprises: 2.5. Mu.L of 10 Xisothermal amplification buffer, 1.4. Mu.L of dNTPs (25 mmol/L), 1. Mu.L of Bst DNA polymerase (8000U/mL).
10 Xisothermal amplification buffer is prepared from Tris-HCl, (NH) 4 ) 2 SO 4 、KCl、MgSO 4 The mixture ratio of the components in the reaction system is as follows:
primer AF F3: 0.2. Mu. Mol/L;
primer AF FIP: 1.6. Mu. Mol/L;
primer AF LF: 0.67. Mu. Mol/L;
primer AF BIP: 1.6. Mu. Mol/L;
primer AF LB: 0.67. Mu. Mol/L;
primer AF B3: 0.2. Mu. Mol/L;
dNTP:0.58mmol/L;
Tris-HCl:16.67mmol/L;
(NH 4 ) 2 SO 4 :8.33mmol/L;
KCl:12.5mmol/L;
MgSO 4 :1.67mmol/L;
Tween-20:0.08%;
bst polymer: 0.27U/mL.
Nucleic acid colloidal gold detection cards are commercially available, for example, from Jiangsu Hunting Biotechnology Inc., under the accession number HDu.
Example 4
Extracting DNA of a sample to be detected by adopting a genome DNA extraction kit;
reagent configuration: the experiment was performed by selecting the kit of example 3, preparing a reaction system by using a 1.5mL centrifuge tube (DNase/RNase-Free, sterilization), adding a mixed solution of a loop-mediated isothermal amplification PCR reaction solution and a primer, performing vortex oscillation for 10 seconds, centrifuging for standby, and sub-packaging 20 mu L/tube into the PCR reaction tube (sterile and DNase/RNase-Free).
Sample adding: the extracted nucleic acid was transferred to each PCR reaction tube by 10. Mu.L, the tube cap of the reaction tube was closed, and transferred to the PCR detection zone after centrifugation.
And (3) PCR amplification: the PCR reaction tube was placed in an isothermal amplification sample tank and reacted at 60℃for 30min.
Preparing a detection card: the test card was removed from the aluminum foil bag and placed on a dry horizontal table top.
Sample adding detection: 20 mu L of sample amplification product is taken into a sample adding hole of a detection card by using a liquid transfer device, 100 mu L of chromatographic buffer solution is added, and the result is read within 2 minutes.
Result determination criteria:
the C line shows red line, and the T line shows red line, which indicates that the detected sample is positive;
the C line shows red line, and the T line does not show red line, which indicates that the detected sample is negative;
the C line has no red line indicating a test card failure.
Example 5
The difference from example 3 was only that the final concentration of the primer AF FIP in the reaction system was replaced with 2.4. Mu. Mol/L.
Example 6
The difference from example 3 was only that the final concentration of the primer AF BIP in the reaction system was replaced with 2.4. Mu. Mol/L.
Example 7
The difference from example 3 was only that the final concentration of primer AF FIP in the reaction system was replaced with 2.4. Mu. Mol/L and the final concentration of primer AF BIP was replaced with 2.4. Mu. Mol/L.
Experimental example 1
A standard strain of Aspergillus fumigatus was prepared by the method of example 4 using the primers shown in example 1Aspergillus fumigatusPurchased from the american type ATCC collection, no. ATCC 1022 DQ), the concentration of the Aspergillus fumigatus sample was about 5000 copies/mL, and the test was repeated 10 times, and the test results are shown in FIG. 1.
As can be seen from FIG. 1, the results of 10 tests are positive to Aspergillus fumigatus and the color development is uniform, which indicates that the combination of the application has good detection consistency.
Experimental example 2 detection sensitivity of Aspergillus fumigatus detection kit
Aspergillus fumigatus is preparedAspergillus fumigatusSamples to be tested, prepared at concentrations of 2500copies/mL, 1000 copies/mL, 500copies/mL, 250 copies/mL and 100 copies/mL, purchased from the American type ATCC accession number ATCC 1022 DQ), were tested according to the method of example 4, each gradient was tested 5 times repeatedly, the results were recorded, and the results were shown in Table 1 below (positive for "+", negative for "-") with the sample concentration at all tested times as the limit of detection:
TABLE 1 sensitivity test results
As a result, 2500copies/mL, 1000 copies/mL and 500copies/mL were all detected, and 250 copies/mL and 100 copies/mL were detected with a probability. Therefore, the detection limit of the combined reagent for aspergillus fumigatus is 500copies/mL, and the sensitivity is high, so that the combined reagent can be used for aspergillus fumigatus nucleic acid detection.
Experimental example 3 specificity of Aspergillus fumigatus detection kit
Aspergillus fumigatus purchased from American ATCCAspergillus fumigatusAF, no. ATCC 1022DQ, aspergillus flavus @ and method for preparing the sameAspergillus flavusAFla, no. ATCC 9643DQ, aspergillus nigerAspergillus nigerAN, no. ATCC 1015 DQ), aspergillus oryzaeAspergillus oryzaeAO, no. ATCC 1011), aspergillus nidulansAspergillus nidulansANi, no. ATCC 10074), cryptococcus neoformansCryptococcus neoformansCN, no. ATCC 32045), cryptococcus gartertiaryanaCryptococcus gattiCG, no. atcc MYA-4562), yersinia pneumosporePneumocystis jiroveciiPJ, no. ATCC MYA-5006 SD), streptococcus pneumoniaeStreptococcus pneumoniaeSP, no. ATCC 49619DQ, staphylococcus aureusStaphylococcus aureusSA, no. ATCC 29213), pertussisBordetella pertussisBP, no. ATCC 9797DQ, haemophilus influenzaeHaemophilus influenzaeHI, no. ATCC 51907 DQ), candida albicansCandida albicansCA, no. ATCC 10231DQ, candida parapsilosisCandida parapsilosisCP, no. atcc 22019 DQ), candida tropicalisCandida tropicalisCT, no. ATCC 66029 DQ) and Saccharomyces cerevisiaeSaccharomyces cerevisiaeA total of 16 samples were subjected to a specificity test by SC, no. ATCC MYA-4941 DQ). The concentration of each sample to be tested was 2500copies/mL and was measured as in example 4.
As shown in FIG. 2, in the detection results of 16 samples, only Aspergillus fumigatus is positive, and the rest are negative, which shows that the combination of the application can eliminate the interference of different pathogens and accurately detect Aspergillus fumigatus.
Experimental example 4 comparison of different primer sets
Primer combinations (nucleotide sequences and modification modes) are key factors influencing the detection capability of a nucleic acid detection platform, and the primer combinations used are required to have higher specificity and sensitivity, so that the preference of the primer combinations is particularly important. In the development stage of the kit, comparison of different primer combinations and different modification modes is carried out.
The application designs the following alternative primers (the sequences are all 5'to 3'):
aspergillus fumigatus alternative primer combination 1 nucleic acid sequence located at positions 561-768 of the ANXC4 CDS region, specifically:
the AF F3-1 primer is positioned in 561-578 positions on the CDS region, and the sequence is: GCTCAATGGTGCTCCTCC, as shown in SEQ NO. 7;
the AF FIP-1 primer is formed by combining two fragments which are separated on CDS, and the fragments are respectively positioned at 597-614 and 643-663 positions on the CDS, and the sequences are as follows: CTGTCCGGGTCTGGCATAGCT-GCGTTCCCGTCATGCTTC as shown in SEQ NO. 8;
AF LF-1 primer is located at 622-642 th bit of CDS region, and has the sequence: GGGATGATGACCGGGAATGTC, as shown in SEQ NO. 9;
the AF BIP-1 primer is similar to the FIP-1 primer and also consists of two fragments which are spaced on the CDS, and are respectively positioned at 666-686 and 729-746 on the CDS, and the sequence is as follows: CCAGTATGCCATGCCGTCACA-GCCCAATTTGACTGCGGT as shown in SEQ NO. 10;
AF LB-1 primer is located at 687-707 th position on CDS region, and the sequence is: GTATGGCCAATTCCAGCCTAG, as shown in SEQ NO. 11;
the AF B3-1 primer is located at 749-768 positions on the CDS region. The sequence is as follows: TCGTTCACACTCTGGAATGG, as shown in SEQ NO. 12;
aspergillus fumigatus alternative primer combination 2 is located in the 384-578 nucleic acid sequence of the ANXC4 CDS region, in particular:
the AF F3-2 primer is positioned at 384-403 th position on the CDS region, and the sequence is GCCAAATCTTCGACCAGTGA, as shown in SEQ NO. 13;
the AF FIP-2 primer is formed by combining two fragments which are separated on CDS, and the fragments are respectively positioned at the 404 th site to the 422 th site and the 464 th site to the 483 th site on the CDS, and the sequences are CAGATCGCTAGGCGCATCGC to CGTATGAGAGTCCCTCGGA, as shown in SEQ NO. 14;
AF LF-2 primer is located in 425-446 th position of CDS region, and has sequence TCGTCCGTATCTGAGTAGGAGT as shown in SEQ NO. 15;
the AF BIP-2 primer is similar to the FIP primer, and also consists of two fragments which are spaced on the CDS, are respectively positioned at 497-517 and 538-557 on the CDS, and have the sequence of ACGGATACAGAAAGCCAGCGC-CCGGACATAACTGGACCATC as shown in SEQ NO. 16;
the AF B3-2 primer is located in 561-578 position on CDS region, and has sequence GGAGGAGCACCATTGAGC as shown in SEQ NO. 17.
Wherein, the concentration of the F3 primer and the B3 primer in each alternative primer combination reaction system is 0.2 mu mol/L, FIP primer and the concentration of the BIP primer are 1.6 mu mol/L, and the concentration of the LF primer (if any) and the LB primer (if any) are 0.67 mu mol/L; the other components and concentrations in the reaction system were the same as in example 3.
A comparison scheme for binding different modification sites on the basis of example 1, comprising:
example 1 (primer AF FIP 5 'labeled FAM group, primer AF LB 5' labeled biotin);
alternative modification scheme 1 (primer AF FIP 5 'end labeled FAM group, primer AF LF 5' end labeled biotin);
alternative modification scheme 2 (primer AF FIP 5 'labeled FAM group, primer AF BIP 5' labeled biotin).
The aspergillus fumigatus standard strain is used as a sample to be tested, and the results are shown in table 2:
table 2 detection results of combinations of primers
The results showed that the detection limit of each of the alternative modification scheme 1, the alternative modification scheme 2, the alternative primer set 1 and the alternative primer set 2 was 1000 copies/mL. In conclusion, the detection limit of the combination is the lowest, and the sensitivity is the highest.
Experimental example 5 comparison of the different primer concentrations
In view of the fact that the primer concentrations of FIP and BIP in the LAMP reaction system have a large influence on the detection sensitivity, different concentration detection comparison experiments of FIP and BIP are performed on the primer set of the application so as to obtain optimal reaction concentrations, and the concentrations of the primer FIP and the primer BIP are adjusted on the basis of example 3, as shown in the following table 3:
TABLE 3 experiment set of different primer concentrations
Each combination was tested using Aspergillus fumigatus standard strain (500 copies/mL) as test sample, and the test was repeated 10 times, and the test method was the same as in example 4, and the results are shown in Table 4:
TABLE 4 detection results of different primer concentrations
As is clear from Table 4, in the case of combinations 5, 6, 8 and 9, that is, in which the FIP and BIP concentrations in the reaction system were not lower than 1.6. Mu. Mol/L, 500copies/mL of the A.fumigatus standard strain could be stably detected, and therefore, the FIP and BIP primer concentrations in the reaction system were set to 1.6. Mu. Mol/L in view of the cost of the reagents.
The foregoing is merely a preferred embodiment of the present application and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present application, which are intended to be comprehended within the scope of the present application.
Claims (10)
1. An aspergillus fumigatus detection primer set, which is characterized by comprising the following primers:
a primer AF F3 with a nucleotide sequence shown as SEQ ID NO. 1;
a primer AF FIP with a nucleotide sequence shown as SEQ ID NO. 2;
the nucleotide sequence is shown as a primer AF LF shown as SEQ ID NO. 3;
the nucleotide sequence is shown as a primer AF BIP shown in SEQ ID NO. 4;
the nucleotide sequence is shown as a primer AF LB shown in SEQ ID NO. 5;
the nucleotide sequence is shown as a primer AF B3 shown in SEQ ID NO. 6.
2. The aspergillus fumigatus detection primer set according to claim 1, wherein the 5' end of the primer AF FIP is labeled with a fluorescent group;
the 5' end of the primer AF LB is marked with biotin.
3. The aspergillus fumigatus detection primer set according to claim 2, wherein the fluorescent group is FAM or FITC.
4. Use of the aspergillus fumigatus detection primer set according to any one of claims 1-3 in the preparation of a kit for detecting aspergillus fumigatus.
5. A kit for detecting aspergillus fumigatus, which is characterized by comprising a detection reagent and the aspergillus fumigatus detection primer set according to any one of claims 1 to 3.
6. The kit for detecting aspergillus fumigatus according to claim 5, wherein the final concentration of the primer AF FIP in the kit is 1.6-2.4 mu mol/L;
the final concentration of the primer AF BIP in the kit is 1.6-2.4 mu mol/L.
7. The kit for detecting aspergillus fumigatus according to claim 5, wherein the detection reagent comprises isothermal amplification buffer, dNTP and Bst DNA polymerase.
8. The kit for detecting aspergillus fumigatus according to claim 7, wherein the isothermal amplification buffer comprises Tris-HCl, (NH) 4 ) 2 SO 4 、KCl、MgSO 4 And Tween-20.
9. The kit for detecting aspergillus fumigatus according to claim 5, wherein the kit further comprises a colloidal gold immunochromatographic test strip.
10. The kit for detecting aspergillus fumigatus according to claim 9, wherein the colloidal gold immunochromatographic test strip comprises a bottom plate, a sample pad, an interpretation zone and a water-absorbing pad; the sample pad, the interpretation area and the water absorption pad are sequentially arranged on the bottom plate; the interpretation area is sequentially provided with a detection line and a quality control line;
FAM antibodies are coated in the detection line, and the concentration of the FAM antibodies is 0.05-0.15 mg/mL;
the quality control line is coated with a biotin-BSA solution, and the concentration of the biotin-BSA solution is 1.5-3 mg/mL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311401969.5A CN117144053B (en) | 2023-10-27 | 2023-10-27 | Aspergillus fumigatus detection primer set, kit and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311401969.5A CN117144053B (en) | 2023-10-27 | 2023-10-27 | Aspergillus fumigatus detection primer set, kit and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117144053A true CN117144053A (en) | 2023-12-01 |
CN117144053B CN117144053B (en) | 2024-01-19 |
Family
ID=88910253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311401969.5A Active CN117144053B (en) | 2023-10-27 | 2023-10-27 | Aspergillus fumigatus detection primer set, kit and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117144053B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105368918A (en) * | 2014-08-21 | 2016-03-02 | 黄耀江 | LAMP primer for detecting Asperillus Parasiticus, and kit including primer |
CN105624290A (en) * | 2016-01-12 | 2016-06-01 | 中国人民解放军疾病预防控制所 | Application of Aspergillus fumigatus annexin anxC4 gene (anxC4 gene) |
CN108486258A (en) * | 2018-01-29 | 2018-09-04 | 南昌大学 | A kind of kit and its method of visual quickly detection food-borne pathogens |
CN108707691A (en) * | 2018-06-07 | 2018-10-26 | 杭州缔蓝生物技术有限公司 | A kind of primer combination of probe of specific detection aspergillus fumigatus and the kit that aspergillus fumigatus is detected based on fluorescent PCR method |
CN109988855A (en) * | 2017-12-29 | 2019-07-09 | 博奥生物集团有限公司 | For detecting the LAMP primer composition and its application of six kinds of aspergillus |
CN110760605A (en) * | 2019-10-31 | 2020-02-07 | 中国人民解放军疾病预防控制中心 | Real-time fluorescence RPA detection kit for aspergillus fumigatus and special primer and probe thereof |
-
2023
- 2023-10-27 CN CN202311401969.5A patent/CN117144053B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105368918A (en) * | 2014-08-21 | 2016-03-02 | 黄耀江 | LAMP primer for detecting Asperillus Parasiticus, and kit including primer |
CN105624290A (en) * | 2016-01-12 | 2016-06-01 | 中国人民解放军疾病预防控制所 | Application of Aspergillus fumigatus annexin anxC4 gene (anxC4 gene) |
CN109988855A (en) * | 2017-12-29 | 2019-07-09 | 博奥生物集团有限公司 | For detecting the LAMP primer composition and its application of six kinds of aspergillus |
CN108486258A (en) * | 2018-01-29 | 2018-09-04 | 南昌大学 | A kind of kit and its method of visual quickly detection food-borne pathogens |
CN108707691A (en) * | 2018-06-07 | 2018-10-26 | 杭州缔蓝生物技术有限公司 | A kind of primer combination of probe of specific detection aspergillus fumigatus and the kit that aspergillus fumigatus is detected based on fluorescent PCR method |
CN110760605A (en) * | 2019-10-31 | 2020-02-07 | 中国人民解放军疾病预防控制中心 | Real-time fluorescence RPA detection kit for aspergillus fumigatus and special primer and probe thereof |
Also Published As
Publication number | Publication date |
---|---|
CN117144053B (en) | 2024-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105441595B (en) | It is a kind of for detecting the digital pcr absolute quantitation parting detecting reagent of HBV-B/C | |
CN106987626B (en) | Primer and probe for rapidly detecting various fungi and identifying strains and application thereof | |
CN117143868B (en) | Cryptococcus neoformans detection primer set, kit and application thereof | |
CN117143867A (en) | Yersinia pneumosporium detection primer group, kit and application thereof | |
CN117144053B (en) | Aspergillus fumigatus detection primer set, kit and application thereof | |
CN110791570B (en) | Primer group and kit for simultaneously detecting Wei-type, Si-type and heterodiscal paragonimiasis | |
CN116814789B (en) | System for cervical cancer high-grade lesion or cervical cancer diagnosis and related gene methylation qPCR detection kit | |
CN114438238B (en) | Primer for detecting infectious endocarditis pathogen and digital PCR kit | |
CN117070668B (en) | Aspergillus flavus detection primer set, kit and application thereof | |
CN105177156B (en) | Human epidermal growth factor receptor gene mutation detection kit and its application | |
CN102181567A (en) | Real-time fluorescent quantitative PCR (polymerase chain reaction) kit for detecting candida glabrata | |
CN106048051B (en) | A kind of candida krusei fluorescence PCR detection reagent kit | |
US20230340563A1 (en) | Tools & methods useful for detection of lactose intolerance and uses thereof | |
CN115873979A (en) | Constant-temperature nucleic acid amplification RAA primer probe combination for detecting candida auricula and application thereof | |
CN102181566A (en) | Real-time fluorescence quantitative PCR (Polymerase Chain Reaction) kit for detecting candida tropicalis | |
CN110055345A (en) | Primer sets and its application | |
CN111560475A (en) | Redondvirus virus nucleic acid detection kit | |
CN107130015B (en) | Fluorescent quantitative PCR kit for detecting aspergillus fumigatus | |
Yuan et al. | Recent advancement in technology for the screening and identification of fungal species | |
CN118086550A (en) | Fluorescent probe combination for detecting fungi in sputum, detection kit and application | |
CN117187416A (en) | Home self-test kit for detecting neisseria gonorrhoeae | |
CN117248017A (en) | Human NRAS gene mutation detection kit and application thereof | |
CN116240212A (en) | CircRNA marker for efficiently diagnosing and identifying tuberculosis and lung cancer as well as NTM infection, detection reagent and kit | |
CN112481369A (en) | Application of MSRB1 as tuberculosis diagnosis molecular marker | |
CN117904329A (en) | Household self-detection kit for detecting mycoplasma genitalium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |